Canada Pension Plan Investment Board
CNST

Canada Pension Plan Investment Board’s Constellation Pharmaceuticals, Inc. CNST Stock Holding History

Canada Pension Plan Investment Board’s Portfolio CNST Stock Details CNST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-115,000
Closed -$3.61M – 1512
2020
Q1 		$3.61M Sell
115,000
-120,000
-51% -$4.17M 0.01% 587
2019
Q4 		$11.1M Buy
235,000
+222,000
+1,708% +$6.41M 0.02% 425
2019
Q3 		$84K Buy
+13,000
New +$109K ﹤0.01% 1128
2019
Q2 		– Sell
-50,000
Closed -$678K – 1580
2019
Q1 		$678K Buy
+50,000
New +$448K ﹤0.01% 1145

Other funds holding CNST

PS
Peter Svennilson $1.23B AUM 301.34% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
VMV
Venrock Management V Palo Alto, California $719M AUM
TG
TRV GP Boston, Massachusetts $18.9M AUM 541.67% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return

Canada Pension Plan Investment Board's CNST Position: Q2 2020 in Review

Canada Pension Plan Investment Board sold out of Constellation Pharmaceuticals, Inc. (CNST) in Q2 2020, closing a stake of 115,000 shares — an estimated $3.61M sold.

Canada Pension Plan Investment Board first reported a position in CNST in Q1 2019 and held it in 4 quarters. The position peaked at $11.1M in Q4 2019. 132 funds tracked by Wall St. Rank hold CNST as of Q2 2020.

  • Canada Pension Plan Investment Board reported no remaining Constellation Pharmaceuticals, Inc. position as of Q2 2020 after selling out during the quarter.
  • Canada Pension Plan Investment Board sold 115,000 Constellation Pharmaceuticals, Inc. shares in Q2 2020, an estimated $3.61M.
  • Canada Pension Plan Investment Board first reported a position in Constellation Pharmaceuticals, Inc. in Q1 2019 and held it in 4 quarters.
  • Canada Pension Plan Investment Board's Constellation Pharmaceuticals, Inc. position peaked at $11.1M in Q4 2019.
  • 132 funds tracked by Wall St. Rank held Constellation Pharmaceuticals, Inc. as of Q2 2020.

Based on Canada Pension Plan Investment Board's 13F filing for Q2 2020, filed 14 Aug 2020.